A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is
Landscape of circulating diagnostic biomarkers in pancreatic malignancies
Annals of Pancreatic Cancer
Pancreatic cancer remains the most lethal adult cancer in the US that is in large part due to the lack of effective early detection biomarkers. Although a variety of blood based technologies have been developed, each of these assays have different advantages and disadvantages. Here, we will review the landscape of blood based biomarkers in the context of pancreatic cancer early detection. Tumor biomarkers (CA19-9, CEA) are widely used, but often have limited specificity to cancer, anddoi:10.21037/apc.2020.03.04 fatcat:lj5jugadurdmxa46psvuvnolly